See All Slides - tctmd.com

Slides

Presentation TCT 2012

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

Presenter: Michael Haude

October 23, 2012

Presentation TCT 2012

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(3)

Presenter: Ian Meredith

October 23, 2012

Presentation TCT 2012

OCT as a Clinical Tool for Vulnerable Plaque Detection: New Insights and Future Studies

Presenter: Shiro Uemura

October 23, 2012

Presentation TCT 2012

Importance of Sustained Patency and the Role of DES for Infrapopliteal Intervention

Presenter: Robert Lookstein

October 23, 2012

Presentation TCT 2012

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

Presenter: Joseph Jakubowski

October 23, 2012

Presentation TCT 2012

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

Presenter: Patrick Serruys

October 23, 2012

Presentation TCT 2012

ELM Presentation(6)

Presenter: Lynn Peng

October 23, 2012

Presentation TCT 2012

TCT-30. Clinical Outcomes Following Radial Versus Femoral Artery Access in Primary or Rescue Percutaneous Coronary Intervention in Scotland: Retrospective Cohort Study of 4534...

Presenter: Colin Berry

October 23, 2012

Presentation TCT 2012

Darapladib and STABILITY Update

Presenter: Harvey White

October 23, 2012

Presentation TCT 2012

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Presenter: Peter Block

October 23, 2012

Advertisement

Slides

TCT-38. Two-year Clinical Data of Cohort 1 and Multi-modality Imaging Results Up to 1-year Follow-up of the BIOSOLVE-I Study with the Paclitaxel-eluting Bioabsorbable...

Early Human Clinical Studies: Patient Selection, Technical Considerations, and Endpoints(3)

OCT as a Clinical Tool for Vulnerable Plaque Detection: New Insights and Future Studies

Importance of Sustained Patency and the Role of DES for Infrapopliteal Intervention

TCT-49. A Comparison of 5 mg Prasugrel with 75 mg Clopidogrel in Very Elderly Coronary Artery Disease Patients: Pharmacodynamics and Rates of High on-Treatment Reactivity

What Will It Take for Focal Therapy of Vulnerable Plaque to Become a Reality? Preclinical and Clinical Insights

ELM Presentation(6)

TCT-30. Clinical Outcomes Following Radial Versus Femoral Artery Access in Primary or Rescue Percutaneous Coronary Intervention in Scotland: Retrospective Cohort Study of 4534...

Darapladib and STABILITY Update

The Spectrum of Late Complications of LAA Closure: Device-Specific Mechanisms, Incidence, and Prevention

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content